🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Colon and Rectal Cancer

AI-Assisted Chemotherapy Side Effect Management NCT07198581NA1 site📍 Incheon Incheon St.Mary's Hospital · Tests: LLM-assisted chemotherapy side effect management Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site📍 Boston Lumicell, Inc. · Tests: LUM015, LUM 2.6 Imaging Device COLON-IM : Microbiota and Immune Infiltrate in Normal, Dysplastic and Neoplastic Colorectal Tissue NCT03841799n/a3 sites📍 Lyon📍 Lyon📍 Lyon Centre Leon Berard Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer NCT06275958Phase 336 sites📍 's-Hertogenbosch📍 Alkmaar📍 Amstelveen Leiden University Medical Center · Tests: Doublet Chemotherapy, Standard Dose (100%), Doublet Chemotherapy, Dose-reduced (75%), Monotherapy, Standard Dose (100%)… Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors NCT07095517Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Tirzepatide Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery NCT06349590Phase 1, Phase 21 site📍 Chicago University of Chicago · Tests: High-fiber/low-fat meals Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC NCT07500259n/a1 site📍 Luxembourg Luxembourg Institute of Health · Tests: Personalized Functional Profiling Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study NCT06719206NA2 sites📍 Uppsala📍 Västerås Mälardalen University · Tests: Digital self-management program A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI NCT07543744Phase 126 sites📍 Arkhangelsk📍 Istra📍 Ivanovo R-Pharm · Tests: RPH-030, Vectibix®, Irinotecan, Calcium Folinate, Fluorouracil Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery NCT04103372NA23 sites📍 Reading📍 Amersham📍 London Imperial College London · Tests: MRI scan, Radiologist training CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer NCT07759921NA1 site📍 Aurora University of Colorado, Denver · Tests: Couple-based Mindfulness Intervention, Health and Wellness Education Control Condition Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Blood sampling for pharmacokinetics Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods NCT05501353n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: no intervention TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer NCT07284849Phase 3293 sites📍 Mobile📍 Tucson📍 Tucson Incyte Corporation · Tests: INCA33890, Placebo, Bevacizumab, FOLFOX Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR NCT07371273Phase 21 site📍 Shanghai Fudan University · Tests: Quadrant-based Intersphincteric Resection KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites📍 Phoenix📍 Tucson📍 Los Angeles Kura Oncology, Inc. · Tests: Darlifarnib, Cabozantinib, Adagrasib A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites📍 Duarte📍 Grand Rapids📍 Long Island City Pfizer · Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer NCT06530303Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamide, Fludarabine, Interleukin-2, Pembrolizumab JS212 Combination Therapies in Metastatic Colorectal Cancer NCT07503756Phase 21 site📍 Shanghai Shanghai Junshi Bioscience Co., Ltd. · Tests: JS212, Capecitabine, Bevacizumab, Oxaliplatin, JS207 AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors NCT07094113Phase 139 sites📍 Duarte📍 Los Angeles📍 Atlanta Amgen · Tests: AMG 410, Pembrolizumab, Panitumumab Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection NCT06698146n/a1 site📍 Chicago Northwestern University Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial] NCT07071961Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Regorafenib (CT), Lorigerlimab Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients NCT07673861NA1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Marsden360 ctDNA test and GTAB review The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer NCT07257653Phase 21 site📍 Hangzhou Zhejiang University · Tests: Cetuximab β；Fruquintinib；, Cetuximab β；Fruquintinib；anti-PD1 antibody；, Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery NCT06405776NA1 site📍 Sichuan West China Hospital · Tests: lidocaine, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy